Patent-infringement issue's with drug screening outside the US

被引:0
作者
Williams, KM
机构
来源
GENETIC ENGINEERING NEWS | 2003年 / 23卷 / 21期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:6 / +
页数:3
相关论文
共 50 条
[31]   Ontario defies US firm's genetic patent, continues cancer screening [J].
Eggertson, L .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (04) :494-494
[32]   Having a patent department alone cannot constitute a specific intent to cause direct infringement under US patent law [J].
Chen, Ping-Hsun .
QUEEN MARY JOURNAL OF INTELLECTUAL PROPERTY, 2015, 5 (04) :516-524
[33]   Perkin-Elmer's patent infringement suit moves forward [J].
不详 .
BIOTECHNOLOGY LAW REPORT, 1999, 18 (03) :271-271
[34]   Across Five Eras: Patent Validity and Infringement Rates in US Courts, 1929-2006 [J].
Henry, Matthew D. ;
Turner, John L. .
JOURNAL OF EMPIRICAL LEGAL STUDIES, 2016, 13 (03) :454-486
[35]   THE LOCATION OF THE CONTEMPLATED SALE AS THE ULTIMATE GUIDE IN "OFFER TO SELL" TRANSNATIONAL US PATENT INFRINGEMENT CASES [J].
Cromar, Scott A. .
UNIVERSITY OF ILLINOIS LAW REVIEW, 2012, (05) :1755-1785
[36]   Recent patent applications in drug screening. [J].
不详 .
Nature Biotechnology, 2007, 25 (8) :869-869
[38]   Court Reconfirms Sinorgchem's Non-Infringement Position in Patent Case [J].
Chen Qi .
China Chemical Reporter, 2010, 21 (14) :10-10
[39]   US drug trials expand outside academic centres [J].
Charatan, F .
BRITISH MEDICAL JOURNAL, 1999, 318 (7196) :1442-1442
[40]   Peplin's first US patent [J].
不详 .
AUSTRALASIAN BIOTECHNOLOGY, 2002, 12 (02) :20-21